Golimumab
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Golimumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $231 million on Golimumab across 32,000 claims for 5,263 beneficiaries.
Golimumab is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $7446.21 to $12977.24 per ML — a 74% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$7446.21 – $12977.24
per ML
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing GOLIMUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SIMPONI 50 MG/0.5 ML SYRINGE | $12977.2440 per ML | — |
SIMPONI 50 MG/0.5 ML PEN INJEC | $12909.9420 per ML | — |
SIMPONI 100 MG/ML PEN INJECTOR | $7446.2126 per ML | — |
Frequently Asked Questions
What is Golimumab used to treat?
Golimumab is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Golimumab?
In 2024, Medicare Part D spent $231 million on Golimumab across 32,000 claims for 5,263 beneficiaries.
How many Golimumab products are on the market?
The Golimumab drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Golimumab?
NADAC reference prices for Golimumab range from $7446.2126 to $12977.2440 per ML — a 74% difference between cheapest and most expensive.
Which manufacturers make Golimumab?
1 manufacturer lists Golimumab in NADAC. Ranked by number of NDCs, the largest are Janssen Biotech, Inc. (3).